Cabaletta Bio (CABA) Share-based Compensation (2018 - 2025)

Cabaletta Bio's Share-based Compensation history runs 8 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Share-based Compensation fell 21.31% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $20.9 million (up 46.64% YoY), while the FY2025 annual figure was $20.9 million, up 7.57% from the prior year.
• Share-based Compensation was $4.3 million for Q4 2025 at Cabaletta Bio, down from $5.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $5.8 million in Q3 2025 to a low of $1392.0 in Q2 2023.
• Historically, Share-based Compensation has averaged $2.6 million across 5 years, with a median of $2.1 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Share-based Compensation slumped 99.91% in 2023, then soared 186394.25% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $1.6 million in 2021, then retreated by 1.44% to $1.6 million in 2022, then soared by 93.35% to $3.1 million in 2023, then soared by 77.35% to $5.4 million in 2024, then decreased by 21.31% to $4.3 million in 2025.
• The last three Share-based Compensation figures came in at $4.3 million (Q4 2025), $5.8 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.